Fox Run Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-30,959
Closed -$210K – 1106
2025
Q4
$210K Buy
30,959
+8,984
+41% +$63K 0.03% 794
2025
Q3
$153K Sell
21,975
-8,934
-29% -$62.1K 0.02% 837
2025
Q2
$189K Buy
+30,909
New +$206K 0.03% 760
2024
Q3
– Sell
-34,328
Closed -$238K – 985
2024
Q2
$238K Buy
34,328
+20,576
+150% +$145K 0.04% 614
2024
Q1
$106K Sell
13,752
-5,866
-30% -$47.1K 0.02% 701
2023
Q4
$172K Buy
+19,618
New +$144K 0.04% 651
2018
Q2
– Sell
-41,080
Closed -$286K – 818
2018
Q1
$286K Buy
+41,080
New +$478K 0.07% 505
2016
Q2
– Sell
-11,200
Closed -$98K – 608
2016
Q1
$98K Buy
+11,200
New +$93.1K 0.07% 384

Other funds holding MDXG

Fox Run Management's MDXG Position: Q1 2026 in Review

Fox Run Management sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 30,959 shares — an estimated $210K sold.

Fox Run Management first reported a position in MDXG in Q1 2016 and held it in 8 quarters. The position peaked at $286K in Q1 2018. 238 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Fox Run Management reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 30,959 MiMedx Group shares in Q1 2026, an estimated $210K.
  • Fox Run Management first reported a position in MiMedx Group in Q1 2016 and held it in 8 quarters.
  • Fox Run Management's MiMedx Group position peaked at $286K in Q1 2018.
  • 238 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.